What question did this study set out to answer?

Assess the quality of evidence and evaluate the risk of bias supporting regulated, reimbursable digital health applications in Germany.

October 1, 2023mHealthOpen Access

Digital health applications from a government-regulated directory of reimbursable health apps in Germany—a systematic review for evidence and bias

View Full Paper

Ask AI

Bookmark

Authors

Systematic review reveals notable evidence-related gaps across reimbursable health apps, indicating an urgent need for stricter quality evaluation.

Assess the quality of evidence and evaluate the risk of bias supporting regulated, reimbursable digital health applications in Germany.
Conducted a systematic review of clinical evidence underlying apps approved in the German digital health application (DiGA) directory.
Assessed the published literature for methodological quality and risk of bias.
Identified critical gaps in the clinical evidence supporting directory-listed digital health tools.
Demonstrated an immediate requirement for more rigorous, detailed assessment frameworks to confirm therapeutic benefits.

Dittrich et al. (2023) studied this question.

View Full Paper

Ask AI

Bookmark

Systematic review reveals notable evidence-related gaps across reimbursable health apps, indicating an urgent need for stricter quality evaluation.